Shopping Cart
- Remove All
Your shopping cart is currently empty
PF-04957325 is a potent and selective inhibitor of PDE8.PF-04957325 has an IC50 of 0.7 nM for PDE8A and 0.3 nM for PDE8B.PF-04957325 can be used to study autoimmune encephalomyelitis.

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 1 mg | $139 | In Stock | |
| 5 mg | $247 | In Stock | |
| 10 mg | $372 | In Stock | |
| 25 mg | $643 | In Stock | |
| 50 mg | $932 | In Stock | |
| 100 mg | $1,390 | In Stock | |
| 1 mL x 10 mM (in DMSO) | $217 | In Stock |
| Description | PF-04957325 is a potent and selective inhibitor of PDE8.PF-04957325 has an IC50 of 0.7 nM for PDE8A and 0.3 nM for PDE8B.PF-04957325 can be used to study autoimmune encephalomyelitis. |
| Targets&IC50 | PDE8A:0.7 nM, PDE8B:0.2 nM |
| In vitro | The PDE8 selective inhibitor PF-04957325 exhibits an IC50 of 0.7 nM for PDE8A and 0.2 nM for PDE8B, while its IC50 for all other PDE isoforms is greater than 1.5 μM [3]. Treatment with PF-04957325 in WT Leydig cells or MA10 cells increases steroid production, but has no effect in PDE8A(-/-)/B(-/-) double knockout cells, indicating the drug's specificity [4]. |
| Molecular Weight | 400.38 |
| Formula | C14H15F3N8OS |
| Cas No. | 1305115-80-3 |
| Smiles | Nc1nc(nc2n(C[C@H]3CN(Cc4nccs4)CCO3)nnc12)C(F)(F)F |
| Relative Density. | 1.81 g/cm3 (Predicted) |
| Storage | store at low temperature,keep away from direct sunlight | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 80 mg/mL (200 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 3.3 mg/mL (8.24 mM), Sonication is recommended. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.